Management of IBS and Anxiety

Pharmacological Treatment

The American College of Gastroenterology recommends starting an SSRI at therapeutic doses as first-line treatment for patients with IBS and comorbid anxiety, addressing both anxiety disorder and gastrointestinal symptoms simultaneously 1, 2
SSRIs are specifically recommended when IBS coexists with depression or anxiety because they effectively treat both psychological and gastrointestinal complaints simultaneously 1, 2
Therapeutic doses of SSRIs, such as sertraline 50-200 mg or paroxetine 20-60 mg, are required for treating established anxiety disorders, with low doses being insufficient 1, 2
If SSRI monotherapy at therapeutic doses for 8-12 weeks provides inadequate response, adding low-dose amitriptyline 10 mg at bedtime, titrating to 30-50 mg, can be considered as second-line treatment 2
TCAs demonstrate clinically meaningful benefit for global IBS relief and abdominal pain, but should not be used as monotherapy in patients with anxiety due to insufficient doses for anxiety treatment 3, 2
Selective noradrenaline reuptake inhibitors may be useful alternatives for patients with IBS and psychological comorbidity, though RCT evidence is limited 1

For patients with predominant diarrhea, loperamide can be used as first-line for diarrhea control, with ondansetron or ramosetron as second-line options, and eluxadoline for more severe diarrhea symptoms 4
For patients with predominant constipation, polyethylene glycol or stimulant laxatives can be used as first-line, with secretagogues as second-line for constipation 5, 3
Antispasmodics or peppermint oil can be used as first-line for abdominal pain, with caution when combining dicyclomine with SSRIs due to additive effects on cardiac conduction and anticholinergic effects 5, 3, 4

Cognitive behavioral therapy or gut-directed hypnotherapy should be initiated alongside pharmacotherapy, as brain-gut behavioral therapies are specifically recommended for IBS with mood disorders 6, 1, 2
A "gentle" dietary approach rather than restrictive elimination diets should be implemented, providing standard dietary advice and avoiding excessive caffeine and large meals 1, 2
The Mediterranean diet may benefit both gut and mental health for patients with substantial psychological symptoms, while strict low FODMAP diets should be avoided in patients with severe anxiety 3, 1

Follow-up should be scheduled at 2-4 weeks initially, then monthly, assessing both gastrointestinal symptoms and anxiety symptoms at each visit 2, 1
Monitoring for SSRI side effects and promptly referring to mental health specialist if psychological symptoms worsen or suicidal ideation emerges is crucial 2, 1

Collaborative care with gastroenterology, dietitian, and mental health providers should be established, assuring the patient of ongoing engagement while coordinating with specialists 1, 2